Senior Principal Machine Learning Engineer
Eli Lilly and Company17 hours ago
Bengaluru, IndiaStaff+
Responsibilities
- Design and build production backend systems for agentic AI applications, including API layers, BFF patterns, session/state management, and streaming.
- Lead resolution of highly complex technical challenges spanning multiple systems.
- Set hands-on engineering standards and own GitOps and engineering-governance practices across the team.
- Make MLOps and platform decisions affecting multiple teams, including deployment topology and observability strategy.
- Drive triage and resolution of complex cross-system production incidents.
- Own architecture for agentic AI systems, including routing, policy enforcement, and RAG/knowledge-registry design.
- Lead evaluation and adoption of agent frameworks, LLMOps practices, and GenAI tooling.
- Implement authentication and authorization flows, including OAuth/OIDC, on-behalf-of token exchange, and secure credential storage.
- Mentor engineers on architecture, design patterns, and production engineering practices.
Requirements
- 11–15 years of hands-on experience with growth into architecture-level ownership across multiple teams or systems.
- Strong proficiency in Python and experience writing clean, testable, production-quality code.
- Experience owning CI/CD, containerization, and orchestration for production ML/AI systems.
- Experience developing or deploying LLM-based applications involving prompt engineering, RAG, or agentic workflows.
- Strong working knowledge of Docker, Kubernetes, and CI/CD pipelines.
- Working knowledge of AWS cloud services and Databricks/Unity Catalog or equivalent enterprise data platforms.
- Bachelor's or master's degree in computer science, computer applications, or a related technical field.
- Excellent verbal and written communication skills and experience working in Agile/Scrum environments.
Categories
About Eli Lilly and Company
Eli Lilly and Company researches, develops, manufactures, and markets prescription medicines and biologics for patients, sold through healthcare providers, pharmacies, and payers. Core therapeutic areas include diabetes, oncology, immunology, neuroscience, and obesity. Founded in 1876 and headquartered in Indianapolis, it is a public company (NYSE: LLY) with global operations and is building a new advanced manufacturing site for gene therapy and other modalities in Lebanon, Indiana.